IL6 and rheumatoid arthritis: Consequently, inhibiting IL-6 presents a promising strategy for managing RA.[12] As a result, the imbalance between inflammatory cytokines and anti-inflammatory states has led to joint damage and the induction of inflammation in the synovial membrane.[5,6] The therapeutic management of RA has largely concentrated on alleviating symptoms due to various etiological factors, including inflammation, preventing tissue damage, and maintaining function.